Premium
Correlation between Human Herpesvirus 6 and 7 Infections after Living Related Liver Transplantation
Author(s) -
Ihira Masaru,
Yoshikawa Tetsushi,
Suzuki Kyoko,
Ohashi Masahiro,
Suga Sadao,
Asonuma Katsuhiro,
Tanaka Koichi,
Asano Yoshizo
Publication year - 2001
Publication title -
microbiology and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.664
H-Index - 70
eISSN - 1348-0421
pISSN - 0385-5600
DOI - 10.1111/j.1348-0421.2001.tb02611.x
Subject(s) - seroconversion , biology , transplantation , antibody , human herpesvirus 6 , serology , titer , immunology , virology , antibody titer , virus , in vivo , herpesviridae , viral disease , medicine , microbiology and biotechnology
Abstract Human herpesvirus 6 (HHV‐6) and human herpesvirus 7 (HHV‐7) are closely related to each other. Interaction between the two viruses at the time of primary HHV‐7 infection is suggested by in vivo and in vitro studies. However, interaction between the two viruses in organ transplant recipients has not been analyzed. We analyzed serially collected plasma samples obtained from 40 living related liver transplant recipients by serological assay (indirect immunofluorescence assay, IFA) and polymerase chain reaction (PCR). Significant increase or seroconversion of HHV‐6 IgG and HHV‐7 IgG antibody titers were observed in 45% and 58% of recipients respectively. Positive rate of IgM HHV‐6 antibody increased up to 35% at 4 weeks after transplantation. However, no remarkable peak in the positive rate of HHV‐7 IgM antibody was demonstrated. HHV‐6 and HHV‐7 DNA were detected in plasma in 15 (38%) and 16 (40%) of the 40 recipients respectively. HHV‐6 DNA was detected in 10 (26%) of the 38 recipients at 2 weeks after transplantation. The positive rate of the virus genome in plasma gradually decreased after that time. HHV‐7 DNA was detected in 5 (14%) of the 37 recipients at 2 weeks after transplantation; no obvious peak in the positive rate of HHV‐7 DNA was demonstrated. Antibody responses involving both HHV‐6 and HHV‐7, including either a significant increase in IgG antibody titers or positive identification of IgM antibody were observed in 17 (43%) of the 40 recipients. Thirteen out of the 17 recipients demonstrated concurrent antibody response against both viruses. HHV‐7 antibody response preceded the HHV‐6 antibody response in 2 of the remaining 4 recipients, whereas the opposite was true in the other 2 recipients. Both HHV‐6 and HHV‐7 DNA were detected in 7 (18%) of the 40 recipients. In 4 of those 7 recipients, DNA from both viruses was concurrently detected, 3 of whom had HHV‐7 DNA repeatedly detected after first detection of the virus DNA. The detection of HHV‐7 DNA preceded the detection of HHV‐6 DNA in 2 recipients, whereas HHV‐6 DNA appeared first in 1 recipient.